Hongchang International Co., Ltd (HCIL) — 10-Q Filings
All 10-Q filings from Hongchang International Co., Ltd. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Hongchang International Revenue Soars 161% on Acquisitions, Profit Rebounds
— Nov 13, 2025 Risk: high
Hongchang International Co., Ltd (HCIL) reported a significant increase in revenue and net income for the three and six months ended September 30, 2025. Revenue -
Hongchang International Swings to Profit on Doubled Revenue
— Aug 14, 2025 Risk: medium
Hongchang International Co., Ltd (HCIL) reported a significant turnaround for the three months ended June 30, 2025, achieving a net income of $499,942 compared -
Hongchang International Files Q3 2024 10-Q
— Nov 13, 2024 Risk: low
Hongchang International Co., Ltd. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, previously known as Heyu Biologi -
Hongchang International Files Q2 2024 10-Q
— Aug 13, 2024 Risk: low
Hongchang International Co., Ltd. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, formerly known as Heyu Biological Tec -
Hongchang International Co., Ltd. Files Quarterly Report (10-Q)
— May 15, 2024 Risk: low
Hongchang International Co., Ltd (HCIL) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Filed a Form 10-Q for the quarterly period ended March 31,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX